澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ACTINOGEN MEDICAL LTD

0.036

-0.001-2.70%

成交量：141.62万

成交额：5.21万

市值：1.29亿

市盈率：-6.23

高：0.037

开：0.037

低：0.036

收：0.037

52周最高：0.072

52周最低：0.019

股本：35.76亿

流通股本：26.08亿

量比：0.69

换手率：0.05%

股息：- -

股息率：- -

每股收益(TTM):-0.006

每股收益(LYR):-0.005

净资产收益率：-110.77%

总资产收益率：-63.83%

市净率：15.38

市盈率(LYR):-7.28

数据加载中...

总览公司新闻资讯公告

ACTINOGEN MEDICAL LTD的Xanamia关键性2B/3期阿尔茨海默试验完成247名参与者的随机分组并开始治疗

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ACW.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.036,"timestamp":1774501920000,"preClose":0.037,"halted":0,"volume":1416198,"delay":0,"changeRate":-0.027027027027027053,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3575597000,"eps":-0.005783,"marketStatus":"未开盘","change":-0.001,"latestTime":"03-26 16:12:00 AEDT","open":0.037,"high":0.037,"low":0.036,"amount":52136,"amplitude":0.027027,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.005783,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1774566000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.037,"openAndCloseTimeList":[[1774479600000,1774501200000]],"volumeRatio":0.6873172081489415,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACW.AU","preClose":0.036,"auctionPrice":0.036,"auctionVolume":20603,"auctionTime":1774561598197,"referenceTime":1774517404089,"auction":1,"marketStatus":"盘前竞价","timestamp":1774561598197}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-63.83%","roe":"-110.77%","lyrEps":-0.004944,"volumeRatio":0.6873172081489415,"shares":3575597000,"dividePrice":0,"high":0.037,"amplitude":0.027027,"preClose":0.037,"low":0.036,"week52Low":0.019,"pbRate":"15.38","psRate":"17.48","week52High":0.072,"institutionHeld":0,"latestPrice":0.036,"eps":-0.005783,"divideRate":0,"volume":1416198,"delay":0,"ttmEps":-0.005783,"open":0.037,"prevYearClose":0.061,"prevWeekClose":0.036,"prevMonthClose":0.041,"prevQuarterClose":0.061,"fiveDayClose":0.036,"twentyDayClose":0.042,"sixtyDayClose":0.06,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACW.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153606662","title":"ACTINOGEN MEDICAL LTD的Xanamia关键性2B/3期阿尔茨海默试验完成247名参与者的随机分组并开始治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1153606662","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153606662?lang=zh_cn&edition=fundamental","pubTime":"2025-12-18 21:02","pubTimestamp":1766062944,"startTime":"0","endTime":"0","summary":"ACTINOGEN MEDICAL LTD的Xanamia关键性2B/3期阿尔茨海默试验完成247名参与者的随机分组并开始治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ACW.AU","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}